Speaking valves enable tracheostomy patients to speak naturally. However, improper use may cause dangerous overpressure, leading to severe complications or even patient's death. We address this life-threatening issue by creating a biomimetic speaking valve, which incorporates an integrated overpressure valve that automatically opens when reaching critical pressure levels. To enhance safety, we integrated a whistle module to provide an audible alert for medical staff. Fundamental research on the Utricularia vulgaris trapdoor inspired our abstracted valve form. Through a comprehensive analysis using generalized linear mixed-effect models, we examined various membrane parameter effects on the function of the biomimetic overpressure valve. This enabled us to adjust the valve's opening pressure to cater to patient's unique requirements, thus potentially saving lives by applying a solution from nature.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11535527PMC
http://dx.doi.org/10.1038/s41598-024-77595-0DOI Listing

Publication Analysis

Top Keywords

speaking valve
8
biomimetic overpressure
8
overpressure valve
8
valve integrated
4
integrated biomimetic
4
overpressure
4
overpressure release
4
release acoustic
4
acoustic warning
4
warning signal
4

Similar Publications

Purpose: Speech-language Therapists (SLTs) are specialists in communication, feeding and swallowing as core members of the paediatric tracheostomy multidisciplinary team (MDT). Inconsistent tracheostomy care leads to staff and family frustration and delayed intervention. Little is known about international SLT tracheostomy practices.

View Article and Find Full Text PDF

Background: The optimal timing for percutaneous coronary intervention (PCI) in patients undergoing transcatheter aortic valve replacement (TAVR) is debatable.

Objectives: The aim of this study was to compare outcomes based on the timing of PCI in stable coronary artery disease patients undergoing TAVR.

Methods: Leveraging the STS/ACC TVT Registry and Medicare Linkage, we analyzed patients with stable coronary artery disease undergoing PCI and TAVR between 2015 and 2023 using the SAPIEN 3 balloon-expandable valve platform.

View Article and Find Full Text PDF

Background: Patients with low-flow, low-gradient (LFLG) aortic stenosis (AS) have precarious hemodynamics and are a fragile population for intervention. Quantification of aortic valve calcification (AVC) severity is a critical component of the evaluation for transcatheter aortic valve replacement (TAVR); this study aims to further clarify its utility for risk stratification in LFLG AS.

Methods: This retrospective study evaluated 467 patients with LFLG AS undergoing TAVR at a large quaternary-care hospital from January 2019 to December 2021.

View Article and Find Full Text PDF

Objective: To describe a novel approach to tracheostomy management in dogs with upper airway trauma.

Case Series Summary: Two dogs with upper airway trauma presented to an emergency department and required immediate intubation. To minimize sedation time, tracheostomy tubes were placed in both dogs.

View Article and Find Full Text PDF

Assessment of bystander coronary artery disease in transcatheter aortic valve replacement (TAVR) patients using noncoronary-dedicated planning computed tomography angiography (CTA): diagnostic accuracy in a retrospective real-world cohort.

Clin Radiol

December 2024

Department of Radiology, Division of General Radiology, Medical University of Graz, Auenbruggerplatz 9, 8036 Graz, Austria; Department of Radiology and Nuclear Medicine, University Hospital Wiener Neustadt, Corvinusring 3-5, 2700 Wiener Neustadt, Austria.

Aim: To assess the diagnostic potential of a noncoronary-dedicated pre-TAVR CT angiography (CTA) conducted as a prospective ECG-gated scan without premedication and standard cardiac reconstructions in evaluating bystander coronary artery disease (CAD) against invasive coronary angiography (ICA) as the gold standard.

Materials And Methods: This retrospective study included 232 patients who underwent both CTA and ICA as part of their pre-TAVR evaluation. Exclusion criteria included prior stent, pacemaker, coronary artery bypass, or valve surgery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!